<p>No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy</p>
Hiromichi Maeda(Kochi Medical School Hospital), Hiroki Yamaue(Wakayama Medical University), Seiko Hirono(Wakayama Medical University), Yoshiyasu Ambo(Hokkaido University of Science), Masayuki Sho(Nara Medical University), Yasuhiro Shimizu(Aichi Cancer Center), Tsutomu Fujii(University of Toyama), Manabu Kawai(Wakayama Medical University), Junichi Sakamoto(Tokai Central Hospital), Hidetoshi Eguchi(Osaka Gakuin University), Hiroaki Nagano(Kyushu University), Mari S. Oba(Yokohama City University), Naru Kondo(Hiroshima University), Ken‐ichi Okada(Wakayama Medical University), Jiro Ohuchida(University of Miyazaki), Yoshiaki Murakami(Hiroshima University), Takahiro Akahori(Nara Medical University), Yasuhiro Kodera(Nagoya Medical Center)
Cited by 0
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation
|Journal of Surgical Oncology|2009|333
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
|Cancer Research|2019|328